JACOB LARSEN: Open Payments
NPI 1558730291 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $485
Food & beverage: $412Education: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| Teva Pharmaceuticals USA, Inc. | 1 | $73 |
| Celgene Corporation | 1 | $32 |
| UCB, Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| TG Therapeutics, Inc. | 1 | $20 |
| ARGENX US, INC. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
Products named: KESIMPTA, BOTOX, QULIPTA, ZEPOSIA, Briviact, UBRELVY, Ocrevus Zunovo, BRIUMVI.
Industry payments across ID — which companies pay providers there.
